<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<atom:link href="https://www.respiratoryeducation.ca/articles.xml" rel="self" type="application/rss+xml" />
		<title>RESPTREC News</title>
		<link>https://www.respiratoryeducation.ca/articles</link>
		<description>For your convenience the Lung Sask Professional Education Portal and RESPTREC provides links to research articles, announcements, studies and other news updates which are posted daily onto the website. Reading these articles can be used towards recertification and continuing education. Watch for upcoming opportunities!</description>
			<item>
				<title><![CDATA[Alcohol Consumption and Small Airways Obstruction]]></title>
				<description><![CDATA[This study found that individuals with heavy alcohol consumption are more likely to show isolated small airways obstruction. Because this is a common trait in asthma and early stages of COPD, it is&nbsp;important to raise awareness among both clinicians and the general population of the potential role of alcohol in the development of obstructive lung diseases.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6493?auth=2f1f8e9523ded63aca2f67a246ac2541</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6493?auth=2f1f8e9523ded63aca2f67a246ac2541</guid>
				<pubDate>Wed, 09 Sep 2026 09:24:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Prognostic Significance of Mild Exacerbations or 1 Moderate Exacerbation in COPD]]></title>
				<description><![CDATA[Study&nbsp;results show that among community-based participants with COPD, even with a low exacerbation burden, mild exacerbations and a single moderate exacerbation in the year before enrollment were associated with more severe CT imaging-defined lung structural abnormalities and a higher incidence of subsequent exacerbations over 3 years of follow-up.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6492?auth=9d13730f80e3a04089e0f118cda93147</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6492?auth=9d13730f80e3a04089e0f118cda93147</guid>
				<pubDate>Wed, 09 Sep 2026 09:22:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Changes in Mucus Radiodensity and New Plug Formation Following Dupilumab Treatment in Asthma]]></title>
				<description><![CDATA[Study&nbsp;results show that dupilumab reduces mucus burden in asthma by resolving persistent plugs and limiting new plug formation; however, some patients retain functionally relevant plugs, which may be persistent and/or newly formed low-radiodensity plugs.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6491?auth=8a160268b4d455f4d26e5910bc2c3904</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6491?auth=8a160268b4d455f4d26e5910bc2c3904</guid>
				<pubDate>Wed, 09 Sep 2026 09:20:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Biologics for Asthma and COPD Exacerbations]]></title>
				<description><![CDATA[This commentry suggests that even if future trials demonstrate their efficacy, biologics should remain adjunctive therapies for a subset of severe exacerbations. They should always be used alongside standard care, not as replacements.&nbsp;]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6490?auth=60998f26c5f399a671ae6c1fab5b7168</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6490?auth=60998f26c5f399a671ae6c1fab5b7168</guid>
				<pubDate>Wed, 09 Sep 2026 09:17:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Asthma, COPD Attacks Down With GLP-1 Drugs]]></title>
				<description><![CDATA[Growing evidence has linked GLP-1 drugs to a reduced risk of exacerbations of asthma and COPD.&nbsp;Semaglutide was associated with a 38% reduction in exacerbations in asthma and 21% in COPD.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6489?auth=b9b8f86ec94349b103ea19d9bf5aab03</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6489?auth=b9b8f86ec94349b103ea19d9bf5aab03</guid>
				<pubDate>Wed, 09 Sep 2026 09:07:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Inhaled Corticosteroid Escalation After a Single Moderate Exacerbation in COPD: Differential Benefit by Exacerbation Subtype]]></title>
				<description><![CDATA[In this study, the benefit of ICS escalation after single moderate exacerbation varied by exacerbation treatment phenotype. Steroid-treated events were associated with a reduced subsequent exacerbation with ICS escalation, whereas antibiotic-treated events did not confer additional benefit from ICS, supporting a more precise approach to ICS escalation beyond exacerbation frequency alone.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6488?auth=2a08d40e645e66464fe21a25cc08a618</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6488?auth=2a08d40e645e66464fe21a25cc08a618</guid>
				<pubDate>Mon, 07 Sep 2026 09:41:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Novel translational pulmonary MRI in paediatrics]]></title>
				<description><![CDATA[Pulmonary MRI can effectively visualise lung structure and function in paediatric patients, providing an ionising radiation-free way to assess disease severity, pathophysiology, progression and response to therapy]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6486?auth=ac9135c60fe612b8b403d4c2ec5b7814</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6486?auth=ac9135c60fe612b8b403d4c2ec5b7814</guid>
				<pubDate>Mon, 07 Sep 2026 09:28:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[ERS/ESGE/ESTS clinical practice guidelines on endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer]]></title>
				<description><![CDATA[Endobronchial and oesophageal endosonography provide accurate and minimally invasive tests for the diagnosis and staging of lung cancer]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6485?auth=40d046a16739c7b420d23dd3fdd2445e</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6485?auth=40d046a16739c7b420d23dd3fdd2445e</guid>
				<pubDate>Mon, 07 Sep 2026 09:27:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Postural relief of dyspnoea is associated with improved neuromechanical coupling in patients with advanced COPD]]></title>
				<description><![CDATA[In patients with advanced COPD and postural differences in dyspnoea perception, adopting the preferred body position is associated with a more harmonious coupling between the neural drive and the mechanical output of the ventilatory pump.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6484?auth=1d20203b8b9683fa5091ee501fc61064</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6484?auth=1d20203b8b9683fa5091ee501fc61064</guid>
				<pubDate>Mon, 07 Sep 2026 09:24:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing]]></title>
				<description><![CDATA[Statistical thresholds such as the LLN define rarity, not disease. Evidence shows that clinically meaningful lung disease often emerges above the 5th percentile, suggesting the need to align diagnostic thresholds with risk rather than distribution.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6482?auth=e0da88be9bc720d3bb9465b794829185</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6482?auth=e0da88be9bc720d3bb9465b794829185</guid>
				<pubDate>Mon, 07 Sep 2026 09:02:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Statement of the European Respiratory Society on the tobacco endgame]]></title>
				<description><![CDATA[The European Respiratory Society recommends that European countries take steps to introduce tobacco endgame-oriented policies]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6481?auth=33dda082afce1694b3db3373d56937cb</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6481?auth=33dda082afce1694b3db3373d56937cb</guid>
				<pubDate>Mon, 07 Sep 2026 08:58:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Cardiovascular effects and mortality of short-acting bronchodilators in asthma and COPD]]></title>
				<description><![CDATA[Increased use of SAMA or SABA+SAMA was associated with increased risks of cardiovascular events and mortality in patients with asthma and COPD. Collecting &ge;3 SABA canisters/year was associated with increased mortality.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6480?auth=ff6eb39bae88ec0096e6172ecea135ff</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6480?auth=ff6eb39bae88ec0096e6172ecea135ff</guid>
				<pubDate>Mon, 31 Aug 2026 07:55:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Mucus plug formation is associated with eosinophilic activation in COPD]]></title>
				<description><![CDATA[Study&nbsp;findings support mucus plugs as a potential imaging biomarker of airway eosinophil activation in COPD. Evaluating both systemic and airway markers of type 2 inflammation may identify patients at greatest risk of mucus plugs.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6479?auth=fab8b456fb1146b29ecb7fdacee28b0b</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6479?auth=fab8b456fb1146b29ecb7fdacee28b0b</guid>
				<pubDate>Sun, 30 Aug 2026 10:09:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Astegolimab for COPD with frequent exacerbations]]></title>
				<description><![CDATA[A study found that astegolimab every 2&thinsp;weeks reduced the annualized rate of moderate/severe exacerbations in a clinically heterogeneous population of participants with COPD and frequent exacerbations.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6478?auth=8b41819985d98b6055215c32c530af9f</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6478?auth=8b41819985d98b6055215c32c530af9f</guid>
				<pubDate>Sun, 30 Aug 2026 10:07:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Defining disease stability in COPD]]></title>
				<description><![CDATA[This study&nbsp;provides further evidence for disease stability as an achievable COPD treatment target that predicts long-term clinical benefits in exacerbations and mortality.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6477?auth=58c06678e382b546f157913b9082f5f6</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6477?auth=58c06678e382b546f157913b9082f5f6</guid>
				<pubDate>Sun, 30 Aug 2026 10:05:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Mepolizumab efficacy in COPD]]></title>
				<description><![CDATA[A study found that mepolizumab improved exacerbation-related outcomes in patients with COPD and type 2 inflammation, characterized by both consistently and intermittently elevated blood eosinophil count. Persistent BEC elevation is not required to identify treatable eosinophilic phenotypes in COPD.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6476?auth=94125e68a8508f63f29a4fc17b31474e</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6476?auth=94125e68a8508f63f29a4fc17b31474e</guid>
				<pubDate>Sun, 30 Aug 2026 10:03:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Dupilumab in COPD: a pooled analysis]]></title>
				<description><![CDATA[A study foud that dupilumab reduced ED visits/hospital admissions of any duration. Patients who experienced moderate and/or severe exacerbations required fewer systemic corticosteroids with dupilumab compared with placebo.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6475?auth=ab7c98ca929beb852d19b2cecbe7c9c2</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6475?auth=ab7c98ca929beb852d19b2cecbe7c9c2</guid>
				<pubDate>Sun, 30 Aug 2026 10:00:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[From mild-to-moderate to severe asthma: risk factors and patient profiles]]></title>
				<description><![CDATA[In patients with mild-to-moderate asthma experiencing their first asthma exacerbation, few (4.1%) patients overall progressed to severe asthma within 5 years, but specific high-risk patient profiles faced risks of up to 30%.&nbsp;]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6474?auth=54b3ca84ccbe1488eef7ae99786b73ce</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6474?auth=54b3ca84ccbe1488eef7ae99786b73ce</guid>
				<pubDate>Sun, 30 Aug 2026 09:58:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Airway mucus plugs in asthma and COPD]]></title>
				<description><![CDATA[Mucus plugs have been previously recognized as an important pathological feature in asthma and chronic obstructive pulmonary disease (COPD), but their clinical role in these diseases has not been explored in depth until recently.&nbsp;]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6473?auth=4226ac3d8bc9eca5b99acdcf1dd28ae7</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6473?auth=4226ac3d8bc9eca5b99acdcf1dd28ae7</guid>
				<pubDate>Sun, 30 Aug 2026 09:53:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Natural course of untreated OSA in adults with coronary artery disease]]></title>
				<description><![CDATA[Most of the CAD patients with moderate to severe OSA improve in OSA severity 1 year after revascularization, probably due to the improved cardiac function, and have a decreased risk for MACCEs compared to individuals with persistent OSA.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6472?auth=b50ce6d164fc6dad738537327fe67c50</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6472?auth=b50ce6d164fc6dad738537327fe67c50</guid>
				<pubDate>Sun, 30 Aug 2026 09:51:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Caregiver perspectives on illness inflection points in COPD]]></title>
				<description><![CDATA[Bereaved caregivers emphasized the need for earlier, more specific prognostic conversations that focus on functional decline and care needs rather than time remaining. Clearer expectations about the illness course and help distinguishing COPD progression from other comorbidities may enable caregivers to recognize illness transitions as meaningful signals. Recognizing oxygen initiation and other illness inflection points as actionable indicators could help clinicians provide timely prognostic information, anticipatory guidance, and supportive care to patients and families across the COPD trajectory.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6471?auth=873c131b704a90ded48bd15ee0888bcc</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6471?auth=873c131b704a90ded48bd15ee0888bcc</guid>
				<pubDate>Sun, 30 Aug 2026 09:49:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Association between body roundness index and asthma in children and adolescents]]></title>
				<description><![CDATA[The Body Roundness Index (BRI), derived from waist circumference and height, may better reflect central adiposity than general body-size measures.&nbsp;Higher BRI was positively associated with current asthma among children and adolescents.&nbsp;]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6470?auth=9bac1d7335edcb1343327bbacc6de690</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6470?auth=9bac1d7335edcb1343327bbacc6de690</guid>
				<pubDate>Tue, 25 Aug 2026 10:11:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Inhaled Corticosteroids Continuation in the First Trimester and Pregnancy Outcomes in Women With Asthma]]></title>
				<description><![CDATA[Continuation of ICSs during the first trimester was not associated with an increased risk of adverse maternal or neonatal outcomes compared with discontinuation.&nbsp;These findings support the continuation of ICS therapy during pregnancy when clinically indicated to maintain asthma control.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6469?auth=3e73491060652c132c77b874aa3eadb1</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6469?auth=3e73491060652c132c77b874aa3eadb1</guid>
				<pubDate>Tue, 25 Aug 2026 10:09:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Healthy diet is associated with better lung function, especially in individuals with COPD]]></title>
				<description><![CDATA[Higher diet quality was associated with better lung function in participants with asthma and COPD, and slower lung function decline in people with COPD compared with those without. These findings support diet as a modifiable factor in respiratory health.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6468?auth=117259612b8f9d5b9abafa638034f204</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6468?auth=117259612b8f9d5b9abafa638034f204</guid>
				<pubDate>Mon, 24 Aug 2026 07:44:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Lung Sask "Asthma Virtual Support Meeting: Fall Flare-ups" - Sep 14, 2026 at 12 pm (CST/SK)]]></title>
				<description><![CDATA[The &quot;September Asthma Spike&quot; is an annual phenomenon where asthma flare-ups and related hospital visits surge, usually peaking around the third week of September. It is primarily driven by returning to school, which leads to increased exposure to respiratory viruses, seasonal allergens, and relaxed summer medication routines.

Join Lung Sask&#39;s Nurse Jill on Monday September 14, 2026 at 12 pm CST/SK via Zoom and learn how we can avoid asthma fall flare-ups.

Please share this information with your patient communities.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6467?auth=8b21ef7d567671e1a2878bd891d01e4e</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6467?auth=8b21ef7d567671e1a2878bd891d01e4e</guid>
				<pubDate>Wed, 19 Aug 2026 13:32:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Creating certainty in uncertainty: improving spirometry interpretation]]></title>
				<description><![CDATA[For those of us writing pulmonary function reports, how many times have we been in the situation where the results are at, or just above, or just below, the lower limit of normal?]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6466?auth=066dd169583e2b7cebfb1e0680571ac4</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6466?auth=066dd169583e2b7cebfb1e0680571ac4</guid>
				<pubDate>Sun, 16 Aug 2026 10:20:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Extreme value analysis has the potential to improve spirometry interpretation]]></title>
				<description><![CDATA[Considering the spirometric measures from people with lung function impairment as a separate distribution from people with healthy lung function provides a more analytic assessment of impairment. Applying extreme value analysis, the relative probability of a spirometric measurement being impaired versus healthy and a more precise definition of the zone of uncertainty potentially provides more objective discrimination of the intersection between the healthy and impaired lung function ranges.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6465?auth=d4ceeffab7a31bb3c691609a846428a5</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6465?auth=d4ceeffab7a31bb3c691609a846428a5</guid>
				<pubDate>Fri, 14 Aug 2026 11:27:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[The Canadian Thoracic Society/Canadian Sleep Society Guideline on the Diagnosis of Obstructive Sleep Apnea in Children]]></title>
				<description><![CDATA[An expert panel conducted a systematic review and meta-analysis examining alternative testing to polysomnography. Recommendations formulation followed a process of proposal, discussion, revisions and voting, considering the evidence, panel members&rsquo; judgment, as well as patient and family preferences.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6464?auth=8975f84e39b3ec64c97796140e80d23f</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6464?auth=8975f84e39b3ec64c97796140e80d23f</guid>
				<pubDate>Wed, 12 Aug 2026 09:50:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Pulmonary Dynamics of the Bronchodilator Response in Volume-Responsive Asthma and COPD]]></title>
				<description><![CDATA[Post-bronchodilator spirometry&nbsp;changes in asthma predominantly reflect reduced airflow resistance and improved expiratory flow,&nbsp;whereas large cohorts demonstrate that a positive bronchodilator response in COPD primarily reflects reduced hyperinflation]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6463?auth=540d932d32eabe7a057884da44b087bb</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6463?auth=540d932d32eabe7a057884da44b087bb</guid>
				<pubDate>Wed, 12 Aug 2026 09:45:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[The Impact of Disease Severity and Symptoms on Anxiety and Depression in Individuals With Idiopathic Pulmonary Fibrosis]]></title>
				<description><![CDATA[Study&nbsp;results show that anxiety and depression are common in patients with IPF and are associated with more dyspnea and lower energy. The mental health burden experienced by patients with IPF needs better recognition and might be helped by targeted symptom management.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6462?auth=d43ac349bb2e229eeb5b87b2a303de6d</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6462?auth=d43ac349bb2e229eeb5b87b2a303de6d</guid>
				<pubDate>Wed, 12 Aug 2026 09:42:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Understanding Pulmonary Fibrosis in Pediatric Interstitial Lung Disease]]></title>
				<description><![CDATA[Study results show that pulmonary fibrosis is a common complication in childhood interstitial lung diseases and becomes more pronounced with age, underscoring the importance of early detection. The higher rate of PF findings in patients with DPLD-A disorders suggests that children with surfactant dysfunction or alveolar developmental abnormalities may be at an increased risk of PF developing. PF may be more common in children with a lower Dlco&nbsp;score, with a DPLD-A disorder, or of an older age.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6461?auth=7d52c8ac12de0590c259b893f61fca2b</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6461?auth=7d52c8ac12de0590c259b893f61fca2b</guid>
				<pubDate>Wed, 12 Aug 2026 09:40:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Linking Lungs and Heart]]></title>
				<description><![CDATA[Study results show that in this long-term screening cohort, progression of centrilobular emphysema&mdash;but not&nbsp;paraseptal emphysema&mdash;was linked to&nbsp;Cardiac Action Program&nbsp;progression, highlighting the value of detailed emphysema assessment in screening programs and supporting CLE as a systemic disorder with prognostic relevance.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6460?auth=23b3ae5b9352ee0fad36f93261b5495a</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6460?auth=23b3ae5b9352ee0fad36f93261b5495a</guid>
				<pubDate>Wed, 12 Aug 2026 09:36:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Differential associations of high ambient temperatures with sleep apnoea and snoring]]></title>
				<description><![CDATA[High temperatures were associated with 38% reduction in odds of snoring, with stronger effects in people with moderate-to-severe sleep apnoea. This may reflect a shift from snoring to obstructive apnoeas during heat-disrupted sleep]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6459?auth=66065280f53df4dc02aa814770d48722</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6459?auth=66065280f53df4dc02aa814770d48722</guid>
				<pubDate>Wed, 12 Aug 2026 09:27:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Pulmonary hypertension associated with interstitial lung disease]]></title>
				<description><![CDATA[Following the 7th World Symposium on PH, this review summarises the current understanding of ILD-PH, including clinical characteristics, prevalence, prognosis, pathogenesis, early detection, therapeutic landscape and future directions for ILD-PH]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6458?auth=9036dc955ba1cd38225904af108340da</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6458?auth=9036dc955ba1cd38225904af108340da</guid>
				<pubDate>Wed, 12 Aug 2026 09:24:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Are “race-neutral” lung volume prediction equations appropriate?]]></title>
				<description><![CDATA[There is a continuum of variation in thoracic structure and volume when equatorial populations are compared with cold-adapted populations. Use of a single &ldquo;race-neutral&rdquo; prediction set can misinterpret inherent differences as differences in lung health.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6457?auth=0c2f4ddf0c8b6d4738e3c2be8d8ac238</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6457?auth=0c2f4ddf0c8b6d4738e3c2be8d8ac238</guid>
				<pubDate>Wed, 12 Aug 2026 09:22:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Clinical practice guideline for long COVID prevention and treatment]]></title>
				<description><![CDATA[This report of the Multidisciplinary Working Group on Long COVID Practice Guidelines (MWG-LCPG) presents clinical guidelines on the prevention and treatment of long COVID]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6456?auth=86827e1af3855a2879a0d075d31e5f64</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6456?auth=86827e1af3855a2879a0d075d31e5f64</guid>
				<pubDate>Wed, 12 Aug 2026 09:21:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Physiological quotients and mortality: redefining lung function interpretation beyond FEV1]]></title>
				<description><![CDATA[It is feasible to derive physiological quotients that are independent of age and, in some cases, sex. These quotients are better at discriminating mortality than existing metrics, providing an alternative standard for lung function interpretation]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6455?auth=99f5be2ef698d9bf5b93b9e0c3db46c8</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6455?auth=99f5be2ef698d9bf5b93b9e0c3db46c8</guid>
				<pubDate>Wed, 12 Aug 2026 09:18:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[The impact of neighbourhood material and social disadvantage on respiratory health across Canada]]></title>
				<description><![CDATA[Living in disadvantaged neighbourhoods is associated with greater airflow obstruction, faster lung function decline, worse exercise capacity and more severe respiratory symptom burden]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6454?auth=ddccea59c2fe3a5c064c56e2751be012</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6454?auth=ddccea59c2fe3a5c064c56e2751be012</guid>
				<pubDate>Wed, 12 Aug 2026 09:17:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Novel translational pulmonary MRI in paediatrics]]></title>
				<description><![CDATA[Pulmonary MRI can effectively visualise lung structure and function in paediatric patients, providing an ionising radiation-free way to assess disease severity, pathophysiology, progression and response to therapy]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6453?auth=5e4449a28188b4576d800de13aef08d1</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6453?auth=5e4449a28188b4576d800de13aef08d1</guid>
				<pubDate>Wed, 12 Aug 2026 09:10:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Fentanyl or morphine for persistent dyspnoea in COPD]]></title>
				<description><![CDATA[This trial investigated low-dose transdermal fentanyl and oral morphine compared to placebo for persistent dyspnoea in stable COPD. No significant differences were found for dyspnoea, sleep, health status, anxiety, hypercapnia or side-effects]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6452?auth=8b8bc212cb9ff22768f19a23cb963c46</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6452?auth=8b8bc212cb9ff22768f19a23cb963c46</guid>
				<pubDate>Wed, 12 Aug 2026 09:08:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Eosinophilic vs Non-Eosinophilic Acute Exacerbations of COPD and Subsequent Cardiovascular Event]]></title>
				<description><![CDATA[Study results show eosinophilic AE-COPD was associated with a significantly lower risk of&nbsp;major adverse cardiovascular events&nbsp;compared with non-eosinophilic AE-COPD. Blood eosinophil count at the time of exacerbation may serve as a valuable biomarker for stratifying not only pulmonary outcomes but also long-term cardiovascular risk in COPD.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6451?auth=4e78717c8d7224f192f4d03362d36bdc</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6451?auth=4e78717c8d7224f192f4d03362d36bdc</guid>
				<pubDate>Mon, 10 Aug 2026 07:40:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[The Canadian Thoracic Society/Canadian Sleep Society Guideline on the diagnosis of obstructive sleep apnea in children]]></title>
				<description><![CDATA[The panel upholds polysomnography as the recommended standard for the diagnosis of OSA in children given the absence of an alternative test that could be considered a replacement. Level 3/Home Sleep Apnea Testing is recommended as an alternative option to diagnose OSA in otherwise healthy children over 5-years of age for whom access to polysomnography is effectively absent.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6450?auth=68d9d1f4a6639618aee7f9b1bd379ec6</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6450?auth=68d9d1f4a6639618aee7f9b1bd379ec6</guid>
				<pubDate>Mon, 03 Aug 2026 14:21:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Respiratory oscillometry is associated with respiratory symptoms and functional outcomes at 6-months post-COVID-19]]></title>
				<description><![CDATA[Oscillometry detected abnormal lung mechanics that were associated with functional impairment and respiratory symptoms but indiscernible by spirometry.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6449?auth=7938055eb08c62c195f0c69c563602c0</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6449?auth=7938055eb08c62c195f0c69c563602c0</guid>
				<pubDate>Mon, 03 Aug 2026 14:18:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Systemic steroids in asthma and COPD exacerbations – moving from unnecessary harm to precise care]]></title>
				<description><![CDATA[espite the well-documented harms associated with systemic steroid use,Citation&nbsp;there has been little progress in reducing their use in clinical practice.&nbsp;This review will examine the pivotal trials that established the current standard of care, highlight recent innovations that challenge this paradigm and conclude with a call to action to improve care for patients with adult asthma and COPD exacerbations.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6448?auth=1ef8205e145da0b04db236ae75e01af2</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6448?auth=1ef8205e145da0b04db236ae75e01af2</guid>
				<pubDate>Mon, 03 Aug 2026 14:14:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Association of asthma and COPD with pertussis risk]]></title>
				<description><![CDATA[Evidence from existing observational studies suggests that asthma and COPD are associated with an increased risk of pertussis infection. The findings indicate that clinical identification and vaccination management should be strengthened to reduce preventable infections and the public health burden.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6447?auth=d6eae588342af082b36e974f5c929986</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6447?auth=d6eae588342af082b36e974f5c929986</guid>
				<pubDate>Sat, 01 Aug 2026 09:03:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Advancing in precision asthma management: The Treat-to-Target by Treatable Traits (T4) framework]]></title>
				<description><![CDATA[The T4 Framework aims to streamline treatment strategies, enhancing patient outcomes by addressing the specific characteristics of severe asthma and facilitating a more effective management pathway. Implementing the T4 Framework may significantly improve the personalization of asthma management, ultimately leading to better control and quality of life for patients with severe asthma.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6446?auth=fba65cf9df0f11bd199ad64a5ca264dc</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6446?auth=fba65cf9df0f11bd199ad64a5ca264dc</guid>
				<pubDate>Sat, 01 Aug 2026 09:02:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Discriminative performance and clinical utility of COPD exacerbation categories for predicting future exacerbations]]></title>
				<description><![CDATA[At least 1 moderate or 1 severe exacerbation over the previous 2&thinsp;years has the highest discrimination and confers the highest clinical utility for predicting high COPD exacerbation risk.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6445?auth=0d325e3dcf980cac5dcdd0e6e83efbb8</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6445?auth=0d325e3dcf980cac5dcdd0e6e83efbb8</guid>
				<pubDate>Sat, 01 Aug 2026 08:52:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Consensus palliative care referral criteria for people with idiopathic pulmonary fibrosis]]></title>
				<description><![CDATA[Consensus referral criteria for specialist palliative care referral in IPF are presented, which emphasize comprehensive needs assessment and open communication between clinicians and patients]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6444?auth=31c32e066ee2bc0860f7f9f51ce033ae</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6444?auth=31c32e066ee2bc0860f7f9f51ce033ae</guid>
				<pubDate>Sat, 01 Aug 2026 08:49:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Clinical practice guideline on treatment of nicotine use in adolescents under 18 years of age]]></title>
				<description><![CDATA[With the rising popularity of e-cigarettes, nicotine use in adolescents is increasing. Recommendations for treatment, however, are limited.&nbsp;A multidisciplinary panel of experts developed an evidence-based guideline for treatment of adolescents with nicotine use.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6443?auth=6757d38c9f21c970bea530bcd025f4e9</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6443?auth=6757d38c9f21c970bea530bcd025f4e9</guid>
				<pubDate>Sat, 01 Aug 2026 08:47:00 -0600</pubDate>
			</item>
			<item>
				<title><![CDATA[Trends in adult exclusive and dual use of combustible and non-combustible tobacco products in USA]]></title>
				<description><![CDATA[Exclusive use of combustible tobacco, primarily cigarettes, is declining but remains the most common pattern, especially in older adults. In contrast, exclusive EC use is displacing combustible use among younger adults. Dual use patterns were low overall and stable across the study period.]]></description>
				<link>https://www.respiratoryeducation.ca/articles/6442?auth=7bb5be9becbcf0ded350f1ea755cba09</link>
				<guid isPermaLink="true">https://www.respiratoryeducation.ca/articles/6442?auth=7bb5be9becbcf0ded350f1ea755cba09</guid>
				<pubDate>Fri, 31 Jul 2026 09:35:00 -0600</pubDate>
			</item>
	</channel>
</rss>
